# Eckert & Ziegler to supply therapeutic radioisotopes to Nucleus Radiopharma

Eckert & Ziegler signed extensive supply agreements to serve as core supplier of Lutetium-177 and Actinium-225 to Nucleus Radiopharma for use in cancer treatment radiopharmaceuticals.

- Type: Contract
- Announced: 2024-01-31
- Status: announced
- Products: Lutetium-177, Actinium-225, therapeutic radioisotopes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eckert & Ziegler](https://endata.com/companies/41023.md) (supplier)
- [Nucleus Radiopharma](https://endata.com/companies/75369.md) (customer)

## Sources

- [lesechos-comfi.lesechos.fr](https://lesechos-comfi.lesechos.fr/press-release/eckert-ziegler-strahlen-und-medizintechnik-ag-etr-euz-eckert-ziegler-to-supply-nucleus-radiopharma-with-therapeutic-radioisotopes-ac-225-and-lu-177-RFnqW4KUxz6), 2024-01-31: "We are pleased to support Nucleus’ activities with our Actinium-225 and Lutetium-177 supply and thus contribute to the advancement of radiotherapies."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.